These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20618362)

  • 41. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
    Yeo SG; Kim DY; Kim TH; Jung KH; Hong YS; Chang HJ; Park JW; Lim SB; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):164-71. PubMed ID: 20004532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Local excision for early rectal cancer in the era of neoadjuvant strategies.
    Tepetes K; Spyridakis ME
    Hepatogastroenterology; 2007 Sep; 54(78):1689-93. PubMed ID: 18019696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical case: impact of down-staging after neoadjuvant chemoradiotherapy on the treatment and prognosis of rectal cancer].
    Benoist S
    Gastroenterol Clin Biol; 2009 Apr; 33(4):289-94. PubMed ID: 19346092
    [No Abstract]   [Full Text] [Related]  

  • 44. [Survival in locally advanced rectal cancer can be improved. Optimal management with centralized investigation and treatment].
    Palmer G; Holm T
    Lakartidningen; 2010 Sep 1-7; 107(35):2014-7. PubMed ID: 21043185
    [No Abstract]   [Full Text] [Related]  

  • 45. Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer.
    Mannaerts GH; Schijven MP; Hendrikx A; Martijn H; Rutten HJ; Wiggers T
    Eur J Surg Oncol; 2001 Apr; 27(3):265-72. PubMed ID: 11373103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.
    Rullier A; Laurent C; Capdepont M; Vendrely V; Belleannée G; Bioulac-Sage P; Rullier E
    Am J Surg Pathol; 2008 Jan; 32(1):45-50. PubMed ID: 18162769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.
    Dolinsky CM; Mahmoud NN; Mick R; Sun W; Whittington RW; Solin LJ; Haller DG; Giantonio BJ; O'Dwyer PJ; Rosato EF; Fry RD; Metz JM
    J Surg Oncol; 2007 Sep; 96(3):207-12. PubMed ID: 17443718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: 'y''u' and 'p' need 'mr' and 'ct'.
    Moran B; Brown G; Cunningham D; Daniels I; Heald R; Quirke P; Sebag-Montefiore D
    Colorectal Dis; 2008 Mar; 10(3):242-3. PubMed ID: 17498205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of response in rectal cancer: we are still far from the "crystal ball".
    Francois E; Gérard JP
    Dig Liver Dis; 2010 Oct; 42(10):675-6. PubMed ID: 20800560
    [No Abstract]   [Full Text] [Related]  

  • 52. Neoadjuvant therapy in rectal cancer.
    Fleming FJ; Påhlman L; Monson JR
    Dis Colon Rectum; 2011 Jul; 54(7):901-12. PubMed ID: 21654259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy: Methodological Issues.
    Sabour S
    Dis Colon Rectum; 2018 Apr; 61(4):e27-e28. PubMed ID: 29521839
    [No Abstract]   [Full Text] [Related]  

  • 54. Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
    Smith FM; Rooney P; Farrell C
    Ann Surg; 2017 Dec; 266(6):e104-e105. PubMed ID: 27232257
    [No Abstract]   [Full Text] [Related]  

  • 55. Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
    Battersby NJ; Moran B; Stelzner S; West NP; Branagan G; Strassburg J; Quirke P; Dattani M; Tekkis P; Ginnerup Pedersen B; Hagemann-Madsen GTR; Gudgeon M; Heald B; Brown G
    Ann Surg; 2017 Dec; 266(6):e116-e118. PubMed ID: 27232254
    [No Abstract]   [Full Text] [Related]  

  • 56. Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?
    Tie J; Semira C; Gibbs P
    Expert Rev Mol Diagn; 2018 Jan; 18(1):1-3. PubMed ID: 28954554
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chemoradiotherapy for resectable lower rectal cancer].
    Saito N; Sugito M; Ito M; Kobayashi A; Nishizawa Y
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():500-4. PubMed ID: 22214011
    [No Abstract]   [Full Text] [Related]  

  • 58. Contact Radiation Therapy for Achieving Organ Preservation in Rectal Cancer After Standard Neoadjuvant Chemoradiation: Looking for a Place in the Sun.
    Habr-Gama A; Perez RO
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):574-576. PubMed ID: 29413272
    [No Abstract]   [Full Text] [Related]  

  • 59. [Multidisciplinary treatment for rectal cancer].
    Konishi T; Fukunaga Y
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(7):571-579. PubMed ID: 32655117
    [No Abstract]   [Full Text] [Related]  

  • 60. NCCN Clinical Practice Guidelines in Oncology: rectal cancer.
    Engstrom PF; Arnoletti JP; Benson AB; Chen YJ; Choti MA; Cooper HS; Covey A; Dilawari RA; Early DS; Enzinger PC; Fakih MG; Fleshman J; Fuchs C; Grem JL; Kiel K; Knol JA; Leong LA; Lin E; Mulcahy MF; Rao S; Ryan DP; Saltz L; Shibata D; Skibber JM; Sofocleous C; Thomas J; Venook AP; Willett C;
    J Natl Compr Canc Netw; 2009 Sep; 7(8):838-81. PubMed ID: 19755047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.